An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III Design

Area of Science:

• Clinical Trials
• Biostatistics
• Drug Development

Background:

• Multiple testing procedures (MTP) are crucial in clinical trials.
• Graphical approaches offer a flexible and communicative alternative for MTP.
• Phase III clinical trial design often involves complex endpoints and dose considerations.

Purpose of the Study:

• To illustrate the application of a graphical approach for multiple testing in a hypothetical Phase III clinical trial.
• To demonstrate how this method can handle multiple endpoints and dose comparisons.
• To showcase the utility of graphical MTP in clinical product development.

Main Methods:

• Introduction of a hypothetical Phase III clinical trial design.
• Inclusion of an active comparator and two doses of a test drug.
• Consideration of a primary efficacy endpoint and a promising secondary endpoint.
• Application of a graphical approach to manage multiple testing issues.

Main Results:

• The graphical approach provides a clear framework for handling multiple endpoints and doses.
• This method facilitates communication of complex statistical designs to diverse stakeholders.
• The proposed design addresses potential superiority and safety concerns through dose selection.

Conclusions:

• Graphical approaches are effective tools for managing multiple testing in complex clinical trial designs.
• This methodology enhances the interpretability and communication of statistical strategies in drug development.
• The illustrated Phase III design integrates efficacy and safety considerations using a robust statistical framework.